About

What we do

We develop technologies to better understand the biology and progression of disease, and how individual patients respond to treatment.

We use those insights to enable more proactive and personalized care, while addressing some of the root causes of high failure rates, high costs, and long development cycles in drug and treatment development.

How we do it

Starting from first principles, we build scalable technology to integrate and harmonize data across the longitudinal patient journey — including multiomics and other biological data, genotype, biomarkers, phenotype, lifestyle, environment, social determinants of health, interventions, and clinical events.

On this foundation, we develop biomedical foundation models centered on the evolving patient journey across biological scales — from molecular and cellular through tissue, organ, and system — and over time.

The models are designed to capture the causal relationships and pathways that shape disease progression and treatment response, connecting evolving biological and clinical states to meaningful endpoints and biomarkers.

They are combined with agentic systems and virtual teams that dramatically scale the processing, integration, and interpretation of multimodal biological and clinical data.

Built on the ApeiroM AI Core, these capabilities are translated into solutions for point-of-care decision support and treatment development.

Our team

Our team brings together AI pioneers and technology experts, informaticians and bioinformatics leaders, biological and clinical researchers, and physicians with decades of experience at the frontier of omics, translational research, and the integration of biological and clinical data from discovery to bedside.